Naturland Holding ZrtBUD:NATURLAND 61 Gross Margin % is 59.06% as of Jun. 2025, which is 8% above its 10-year median of 54.78. GuruFocus rates BUD:NATURLAND with a GF Score™ of 61/100 and a GF Value™ of Ft2,879.22 (Fairly Valued). The stock has 6 warning signs investors should review. Among 938 Drug Manufacturers companies, Naturland Holding Zrt ranks better than 65.46% on this metric.
BUD:NATURLAND's Gross Margin % is ranked better than 65.46% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.44
vs BUD:NATURLAND: 58.15
Naturland Holding Zrt had a gross margin of 59.06% for the quarter that ended in Jun. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Naturland Holding Zrt was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Naturland Holding Zrt had a gross margin of 59.06% for the quarter that ended in Jun. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Naturland Holding Zrt Gross Margin % Related Terms
Naturland Holding Zrt Gross Margin % Historical Data
* Premium members only.
The historical data trend for Naturland Holding Zrt's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BUD:NATURLAND vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Naturland Holding Zrt's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturland Holding Zrt Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Naturland Holding Zrt's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Naturland Holding Zrt's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Naturland Holding Zrt (BUD:NATURLAND) has a Gross Margin % of 59.06% as of Jun. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Naturland Holding Zrt and its competitors. This is near median its historical median of 54.78. Over the past decade, Naturland Holding Zrt's Gross Margin % has ranged from 52.62 to 97.22. According to the industry distribution chart, Naturland Holding Zrt ranks #324 out of 938 companies in the Drug Manufacturers industry, placing it in the top 34.5%.
Is Naturland Holding Zrt's Gross Margin % too high?
Naturland Holding Zrt's current Gross Margin % of 59.06% is near median its 10-year median of 54.78. Over the past 10 years, this metric has ranged from a low of 52.62 to a high of 97.22. The Drug Manufacturers industry median Gross Margin % is 48.44. Naturland Holding Zrt's value of 59.06% is 21.9% above this industry median. Based on the distribution chart, Naturland Holding Zrt ranks #324 out of 938 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Naturland Holding Zrt has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Naturland Holding Zrt's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Naturland Holding Zrt ranks #324 out of 938 companies for Gross Margin %. This puts Naturland Holding Zrt in the upper half of its industry. The industry median Gross Margin % is 48.44. Naturland Holding Zrt's value of 59.06% is 21.9% above this benchmark. Historically, Naturland Holding Zrt's own Gross Margin % has ranged from 52.62 to 97.22 over the past decade. While the company's 10-year median is 54.78 vs. the industry median of 48.44, Naturland Holding Zrt has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturland Holding Zrt's current Gross Margin % of 59.06% is 21.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Naturland Holding Zrt and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturland Holding Zrt's current Gross Margin % is 59.06%, which is near median its own 10-year median of 54.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturland Holding Zrt stock overvalued right now?
Based on GuruFocus' analysis, Naturland Holding Zrt (BUD:NATURLAND) is currently considered Fairly Valued. The stock's GF Value™ is Ft2,879.22, compared to a current price of Ft2,820.00 — trading 2.1% below its estimated fair value. The current Gross Margin % is 59.06%, which is near median its 10-year median of 54.78 and 21.9% above the Drug Manufacturers industry median of 48.44. Naturland Holding Zrt's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Naturland Holding Zrt (BUD:NATURLAND), the current Gross Margin % is 59.06% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturland Holding Zrt (BUD:NATURLAND) Overvalued in 2026?
Based on GuruFocus' analysis, Naturland Holding Zrt stock appears to be undervalued.
The current stock price of Ft2,820.00 is trading 2.1% below its estimated GF Value™ of Ft2,879.22.
GuruFocus considers Naturland Holding Zrt to be Fairly Valued.
Key valuation signals for BUD:NATURLAND:
Gross Margin %: 59.06% (near median its 10-year median of 54.78)
GF Value™: Ft2,879.22 vs. price of Ft2,820.00 (2.1% below fair value)
Industry Position: 21.9% above the Drug Manufacturers median (#324 of 938)
No single metric tells the full story. See the BUD:NATURLAND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.
61GF Score
Get the complete analysis for BUD:NATURLAND
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUD:NATURLAND has been successfully added to your 
